Delivery Order SPE2DB20D3103-SPE2DB24FN6D8
Award Date 4/29/24
Potential Completion Date 4/30/24
Potential Value $4.1K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of the pharmaceutical product Rebif Rebidose 44 mcg/0.5 mL, 0.5 mL. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 21, 2021. The contract has a ceiling value of $4,410.72 and is a firm fixed-price delivery order with the Defense Logistics Agency (DLA). Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which operates under the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Rebif Rebidose 44 MCG/0.5 ML 0.5ML, a specialty medication. The contract, with a ceiling value of $4,648.46, is a Firm Fixed Price Delivery Order that does not have a set-aside designation, indicating open competition. AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., is a key vendor for the DLA's Troop Support...
- This federal contract award is a delivery order for the pharmaceutical product Rebif Rebidose 44 mcg/0.5 ml, placed with the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,986.72, was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
- This federal contract award is for the delivery of Rebif Rebidose 44 mcg/0.5 ml prescription medication to the Defense Logistics Agency (DLA). The $13,945.38 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on May 18, 2022, with a completion date of May 19, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice Federal Bureau of...
- This federal contract award is for the delivery of REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,206.68 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of July 30, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
- This federal contract award, with a ceiling value of $4,410.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of the pharmaceutical product Rebif Rebidose 44 mcg/0.5 ml, a multiple sclerosis medication. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen's parent company, Cencora,...
- This federal contract award is for the delivery of Rebif 44 mcg/0.5 mL syringes to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $127,917.04 and an ultimate completion date of July 28, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System...
- This federal contract award is for the delivery of Rebif 44 mcg/0.5 mL syringes to the Defense Logistics Agency (DLA). The award, valued at $6,179, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc. The IDC, valued at up to $999,999,999, is the primary vehicle for Cencora, Inc. to provide a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Rebif 44 mcg/0.5 mL syringes. The $14,235.71 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
- This federal contract award is for the delivery of REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $12,154.39 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 3, 2024 with a completion date of July 5, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...